Winship Lung Cancer SPORE pilot grants

The Winship Lung Cancer Specialized Program of Research Excellence (SPORE) offers pilot grants of up to $50,000 each to support projects focused on career enhancement or developmental research in the area of lung cancer.

Career Enhancement Program Pilot Grant

The Winship Lung Cancer SPORE aims to promote the advancement of early career lung cancer investigators through the conduct of a mentored Career Enhancement Program (CEP). The CEP aims to provide an environment that enables talented early career investigators to engage in a two-year mentored research program and to facilitate their success and their academic career development in terms of achieving independent investigator status.

Eligible candidates (criteria listed below) are encouraged to submit proposals to be funded for two years upon successful completion of the first year, with a maximum of $50,000 per year in direct funds. Proposals relevant to lung oncology with high translational significance and innovation are requested, and will be reviewed by the SPORE's CEP Review Committee prior to any funding decisions. Awardees are expected to provide twice-annual progress reports to the CEP Committee and to present their progress twice annually at the Lung Cancer SPORE investigator meeting. Awardees are granted access to the SPORE Administrative, Pathology, and Biostatistics and Bioinformatics core resources and opportunities for collaboration that arise from membership in the SPORE.

The application process for the 2021 cycle is closed.

Developmental Research Program Pilot Grant

The Winship Lung Cancer SPORE Developmental Research Program (DRP) aims to identify new and innovative research opportunities by supporting meritorious proposals that could expand into full research projects in the future, including those of high risk-high reward projects that might otherwise not be funded; to foster collaborative research between investigators; and to enhance translational research in lung cancer by increasing the number of meritorious investigators working on lung cancer.

DRP pilot projects must conduct basic, translational or clinical research into the cause, prevention, detection or treatment of lung cancer. Awards will be in the amount of $50,000 for a 1-year project period. Proposals relevant to lung oncology with high translational significance and innovation are requested, and will be reviewed by the SPORE's DRP Review Committee prior to any funding decisions. Awardees are expected to provide twice-annual progress reports to the DRP Committee and to present their progress twice annually at the Lung Cancer SPORE investigator meeting. Awardees are granted access to the SPORE Administrative, Pathology, and Biostatistics and Bioinformatics core resources and opportunities for collaboration that arise from membership in the SPORE. Pilot project renewals for a second year are considered on a competitive basis and will be judged on progress, relevance to lung cancer, translational potential, and the potential to grow into a full project. Individual investigators are eligible to submit additional proposals in subsequent years.

The DRP cycle will reopen to solicit additional applications. Please see the revised RFP attached.

Revised dates are as follows:

  • RFP Launch Date: Sunday, August 1, 2021
  • Application Due Date: Tuesday, August 31, 2021
  • Notice of Award Date: Wednesday, September 15, 2021

Excellence Through Diversity

Applications are welcomed from candidates at Emory University and other institutions in the state of Georgia, and from women, minorities, and individuals with disabilities. To support excellence and diversity among pilot grant applicants and awardees, proposals are encouraged from groups identified as nationally underrepresented in the sciences including women, members of underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds.

Contact Information

For inquiries regarding Winship's Lung Cancer SPORE pilot grants, please email the program coordinator.

2021

Career Enhancement Program pilot grant recipients:

Developmental Research Program pilot grant recipient:

  • The mechanism underlying the sex-based difference in the growth of LKB1- mutant lung adenocarcinoma in nude mice
    Wei Zhou, PhD

2020

Career Enhancement Program pilot grant recipients:

  • Discovery of new therapeutic options for lung cancer patients with lost tumor suppressor genes
    Andrey Ivanov, PhD
  • Deconstructing lung cancer heterogeneity in collective invasion and metastasis
    Janna Mouw, PhD

Developmental Research Program pilot grant recipients:

  • Role of Hippo signaling in maintaining metabolic heterogeneity for NSCLC metastasis
    Mala Shanmugam, PhD, MS
  • Modulation of SREBP1/lipid metabolism in EGFR-targeted lung cancer therapy
    Shi-Yong Sun, PhD

2019

Career Enhancement Program pilot grant recipients:

  • A rapid and genetically tractable whole animal model to identify novel vulnerabilities in lung cancer
    Melissa Gilbert-Ross, PhD
  • Identifying and Targeting the Immune-Dependent Vulnerabilities in Non-Small Cell Lung Cancer
    Xiulei Mo, PhD

Developmental Research Program pilot grant recipients:

  • Elucidating B cell responses in NSCLC with checkpoint inhibitor therapy
    Ignacio Sanz, MD
  • Targeting novel metabolic signaling factors in metastatic lung cancer
    Sumin Kang, PhD
Cascade Link  TOP